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 Role of Transcriptional Activation of IKBax
 in Mediation of Immunosuppression
 by Glucocorticoids
 Robert 1. Scheinman,* Patricia C. Cogswell, Alan K. Lofquist,t
 Albert S. Baldwin Jr.t
 Glucocorticoids are potent immunosuppressive drugs, but their mechanism is poorly
 understood. Nuclear factor kappa B (NF-KB), a regulator of immune system and inflam-
 mation genes, may be a target for glucocorticoid-mediated immunosuppression. The
 activation of NF-KB involves the targeted degradation of its cytoplasmic inhibitor, IKBY,
 and the translocation of NF-KB to the nucleus. Here it is shown that the synthetic
 glucocorticoid dexamethasone induces the transcription of the IKBc gene, which results
 in an increased rate of IKBa protein synthesis. Stimulation by tumor necrosis factor causes
 the release of NF-KB from IKBa. However, in the presence of dexamethasone this newly
 released NF-KB quickly reassociates with newly synthesized IKBc, thus markedly reduc-
 ing the amount of NF-KB that translocates to the nucleus. This decrease in nuclear NF-KB
 is predicted to markedly decrease cytokine secretion and thus effectively block the
 activation of the immune system.
 Glucocorticoids (GCs) have been used for
 decades as clinical tools to suppress both
 the immune response and the processes of
 inflammation (1), yet the immLunosuppres-
 sive mechanism by which these drugs act is
 poorly understood. GCs bind to a cytoplas-
 mic glucocorticoid receptor (GR), a mem-
 ber of the steroid hormone receptor super-
 family, which then translocates to the nu-
 cleus as a transcription factor (2). Tran-
 scriptional activation of cytokine and cell
 adhesion genes is critical in the activation
 of tlhe immune and inflammation systems
 and is repressed by GCs (3). GC repressive
 elements, however, have not been found in
 cytokine promoters. In addition, the GR is
 able to repress the transcription factor AP- 1
 through a cross-coupling mechanism (4),
 yet AP-1 regulates only a small number of
 GC-sensitive cytokine promoters. GCs can
 also repress members of the NF-KB-Rel
 transcription factor family (5, 6). NF-KB-
 responsive elements are required for the
 function of many cytokine promoters (7),
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 and NF-KB-responsive elements in the in-
 terleukin-6 (IL-6) and IL-8 promoters have
 been implicated in GC-mediated suppres-
 sion (5). A major form of NF-KB is com-
 posed of a dimer of p50 and p65 (ReIA)
 subunits, and this complex is retained in the
 cytoplasm by repressor molecules that con-
 tain ankyrin repeat motifs (7). These inhib-
 itory molecules include the IKB family:
 IKBox, P, and 'y, as well as the NF-KB pre-
 cursor molecules plO5 (NF-KB1) and plOO
 (NF-KB2) (7-9). Although a cross-coupling
 mechanism of inhibition exists between
 NF-KB and tlhe GR (5, 6), it cannot fully
 explain the ability of GCs to inhibit NF-KB.
 Here it is shown that GCs induce the tran-
 scription of the gene encoding IKBox. The
 increase in IKBox mRNA results in in-
 creased IKBo- protein synthesis, which effec-
 tively inhibits NF-KB activation.
 We initiated this study by extending our
 analysis of the ability of the synthetic GC
 dexamethasone (DEX) to block the induc-
 tion of NF-KB-like DNA binding activities
 in several cell types and by several different
 inducers. As shown previously (6), DEX
 blocks the induction of NF-KB by tumor
 necrosis factor ox (TNF-ox) in HeLa cells
 (Fig. IA, left panel) as well as induction by
 IL-1 (10). The identity of this complex as
 NF-KB was determined by supershift exper-
 iments (10). DEX inhibited the induction
 of NF-KB in the monocytic cell line THP-1,
 mediated by TNF-c- (Fig. IA, middle panel)
 and by lipopolysaccharide (LPS) (10). DEX
 also inhibited the TNF-o-mediated induc-
 tion of NF-KB in the murine T cell hybrid-
 oma 2B4 (Fig. IA, right panel). In addition,
 thymocytes and lymph nodes derived from
 mice treated with monoclonal antibody
 (mAb) to CD3 in combination with DEX
 no longer express NF-KB activity as com-
 pared with mice treated with CD3 mAb
 alone (11). This effect of DEX requires
 protein synthesis, as it is blocked by cyclo-
 heximide (CHX) (Fig. IA, right panel).
 DEX treatment results in a reduction in
 NF-KB-mediated gene expression as mea-
 sured by transfected reporter constructs (5,
 6, 11). Previous work indicated that the
 inhibition of NF-KB was the result in part of
 a decrease in nuclear translocation after
 stimulation with TNF-ox.
 We wanted to determine if the DEX-
 mediated reduction of nuclear p65 translo-
 cation, after TNF-c- stimulation, correlated
 with an increase in IKBox. IKBox is rapidly
 degraded after TNF-a- addition (7, 12) (Fig.
 iB, top left panel) and this loss correlates
 with the appearance of nuclear p65 (Fig.
 IB, bottom left panel). After 1 hour in the
 presence of TNF-a-, IKBo- protein begins to
 reappear as a result of the induction of gene
 transcription by NF-KB (Fig. IB, top panel,
 lane 5). After pretreating HeLa cultures
 with DEX, we observed a small but measur-
 able increase in IKBc- protein (Fig. iB, top
 panels; compare lanes 1 and 6). The aver-
 age increase in IKBox protein was measured
 as 1.5-fold (n = 10). DEX pretreatment h-ad
 no effect on cytoplasmic p65 amounts (10).
 In addition, DEX pretreatment slowed the
 disappearance of IKBo- mediated by TNF-ox.
 After 1 hour of TNF-a- treatment, the
 amount of translocated nuclear p65 was
 reduced approximately 50% in DEX-treated
 cultures as compared with untreated cul-
 tures (Fig. iB, bottom panels; compare
 lanes 5 and 10). THP-1 cultures induced
 with TNF or LPS gave similar results (10).
 We then considered whether DEX might
 induce other NF-KB-sequestering mole-
 cules such as the recently cloned IKBI (13).
 HeLa cells cultured with DEX for 5 hours
 were compared with untreated HeLa cul-
 tures, and no differences were found in
 amounts of IKBI (10). Whereas IKBI is
 insensitive to TNF treatment, LPS induc-
 tion for 2 hours is sufficient to induce re-
 lease of NF-KB and IKBI degradation (13).
 Pretreatment with DEX had no effect on
 either IKB3 amounts or LPS-induced IKBI
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 loss (10). Thus, DEX selectively increases
 the abundance and overall stability of the
 IKBa population.
 In order to determine if the GC-mediat-
 ed increase in lKBa protein was preceded by
 an increase in IKBa mRNA, Northern
 (RNA) blot analysis was done on mRNA
 derived from HeLa cultures treated with
 DEX for increasing periods of time. DEX
 induced a marked increase in lKBa mRNA
 abundance, which peaked by 1 to 2 hours
 (Fig. 2A) and in some cases remained ele-
 vated for over 20 hours (10). A similar
 pattern was observed with THP- 1 cultures
 (10) and is consistent with other studies
 (11). We tested whether protein synthesis
 was necessary for this induction of the IKBa
 message. HeLa cultures were treated with
 DEX in the absence or presence of CHX,
 and IKBa mRNA amounts were compared
 by Northern blot analysis. CHX alone in-
 duced IKBa mRNA, as has been observed
 for other messages (Fig. 2B, lane 2). CHX
 plus DEX superinduced IKBa mRNA (Fig.
 2B, lane 4), indicating that DEX does not
 function by inducing the synthesis of an
 co + c ' co + + I
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 Fig. 1. DEX-mediated repression of NF-KB. (A)
 HeLa cultures were pretreated for 12 hours with
 10-7 M DEX and stimulated for 1 hour with TNF-a
 (1 ng/ml). THP-1 cells and 2B4 murine T cell hy-
 bridomas were pretreated for 5 hours with 10-7 M
 DEX and stimulated for 1 hour with TNF-a (1 ng/
 ml). Nuclear extracts were analyzed by electro-
 phoretic mobility-shift assay with the murine major
 histocompatibility complex class I NF-KB DNA
 binding probe UV21 as described (6). Data are
 representative of six independent experiments.
 (B) HeLa cultures were pretreated with 10-7 M
 DEX for 2 hours and stimulated with TNF-a (1
 ng/ml) for periods of time shown at the top of the
 figure. Cytoplasmic (Cyt.) and nuclear (Nuc.) ex-
 tracts were normalized for protein amounts and
 analyzed by immunoblotting with IKBax and p65
 antibodies to peptide (obtained from Rockland,
 Boyertown, Pennsylvania).
 intermediary factor which must then induce
 the IKBa message. These data suggest that
 GCs directly activate IKBa gene transcrip-
 tion. We tested this hypothesis by perform-
 ing run-on transcription assays on HeLa
 and THP-1 cultures after DEX treatment
 for various periods of time (Fig. 2C). DEX
 clearly increased RNA polymerase occu-
 pancy on the IKBa gene within 15 min and
 A DEX (hours)
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 Fig. 2. DEX induces IKBQx gene transcription. (A)
 Northern blot analysis of HeLa total RNA. HeLa
 cultures were treated for increasing periods of
 time with 10-7 M DEX and harvested for RNA.
 RNA was prepared as described (17). Equal
 amounts of RNA (10 ,g) as determined by
 ethidium-stained 28S RNA were size separated
 by formaldehyde acrylamide gel electrophoresis,
 blofted to Zetaprobe (Bio-Rad), and processed
 according to the manufacturer's instructions. The
 blot was probed first with a MAD-3-IKBa comple-
 mentary DNA (cDNA) (8) labeled by random prim-
 ing. Subsequently, the blot was reprobed with a
 cyclophilin (Cyc.) cDNA (labeled as above) as a
 control RNA. Prehybridization and washing were
 done according to Bio-Rad's recommendations.
 (B) Cultures were treated with CHX (10 ng/ml) for
 1 hour; 1 0- M DEX was then added to appropri-
 ate cultures for an additional 2.5 hours, and RNA
 was harvested and analyzed by Northern blot as
 described above. (C) Run-on transcription assays
 were done on cultures treated with either 10-7 M
 DEX or TNF-a (1 ng/ml) for varying periods of time
 as shown. Nuclei were isolated, and run-on tran-
 scriptions were done as described (18). The filters
 were exposed to a Phospholmager (Molecular
 Dynamics) screen, and the bands were quantitat-
 ed. IKBax and IL-8 transcription were normalized to
 actin transcription. The data are representative of
 four independent experiments.
 for at least 2 hours. In order to quantitate
 the effect, we normalized the IKBa signal to
 an actin control, thereby measuring the
 increase in transcription as almost 10-fold
 (Table 1). We cannot discount the possi-
 bility that actin transcription may be slight-
 ly inhibited by DEX treatment, thus de-
 creasing the amount of the induction, but
 the interpretation of the data remains un-
 affected. In addition, DEX had no effect on
 transcription of genes encoding c-Myc or
 TNF-a (10). TNF-a treatment, in compar-
 ison, induces both IKBa and IL-8 transcrip-
 tion (Fig. 2C and Table 1). No change in
 IKBa mRNA stability was detected as mea-
 sured after actinomycin D treatment in the
 absence or presence of DEX (10). Prelimi-
 nary data indicated that a IKBa promoter
 construct extending to position -600 was
 not activated by DEX (10), which suggests
 that the putative GC-responsive element is
 located further upstream or within the gene.
 Taken together, these data suggest that
 DEX increases IKBa protein abundance
 through an increase in gene transcription.
 The increase in IKBa gene transcription
 induced by DEX was much greater than the
 average increase in IKBa protein abun-
 dance as measured by protein immunoblot.
 We thus wanted to determine if the rate of
 IKBa protein synthesis increased in a man-
 ner similar to that of the mRNA popula-
 tion. We metabolically labeled HeLa cells
 in the absence or presence of DEX, prepared
 whole-cell extracts, and immunoprecipi-
 tated with an antibody specific for either
 IKBa or p65. DEX induced a three- to
 fivefold increase in the rate of incorpora-
 tion of 35S-labeled methionine into the
 IKBa pool (Fig. 3A, compare lanes 1 and 3).
 The p65 antiserum immunoprecipitated al-
 most as much labeled IKBa as did the IKBa
 antiserum, suggesting that the majority of
 newly synthesized IKBo was associated with
 p65 (Fig. 3A, compare lanes 3 and 4). De-
 tection of coimmunoprecipitated p65 by
 the IKBo antiserum was obscured by a
 comigrating nonspecific band (Fig. 3A,
 lanes 1 to 3). In addition, the degree of
 incorporation of label into the p65 pool was
 Table 1. Fold activation of transcription normal-
 ized to actin. Number of experiments, n.
 Average* Experi-
 Condition Avera ments
 (?SD) IKBa ~~(n)
 Control 1.00 (0.07) 3
 DEX (15 min) 9.88 (1.73) 2
 DEX(30 min) 10.06 (3.74) 4
 DEX(1 hour) 11.08 (4.66) 4
 DEX (2 hours) 7.54 (0.59) 2
 TNF-a (1 hour) 23.5 (17.77) 2
 *Experiments such as those shown in Fig. 20 were quan-
 titated with a Phospholmager. Radioactivity was normal-
 ized to actin and expressed as fold increase over control.
 284 SCIENCE * VOL. 270 * 13 OCTOBER 1995
This content downloaded from 152.2.62.71 on Tue, 20 Mar 2018 14:48:10 UTC
All use subject to http://about.jstor.org/terms
 i REPORTS
 much reduced as compared with lKBot, even
 though the two proteins contained similar
 numbers of methionines, indicating that
 the rate of p65 synthesis was low. These
 data indicate that newly synthesized lKBo is
 incorporated into preexisting NF-KB com-
 plexes, which is consistent with previous
 results (14). We tested this hypothesis fur-
 ther by labeling HeLa cultures for short
 periods of time and determining the effi-
 ciency of immunoprecipitation of IKB by
 the two antisera. After a 15-min pulse, ex-
 tract was prepared and divided into identi-
 cal aliquots, one of which was incubated
 with the IKBo antisera and the other with
 the p65 antisera. Once again, the IKBo
 signal derived from the p65 immunoprecipi-
 tation was similar to that derived from the
 IKBot immunoprecipitation (Fig. 3B, lanes 1
 A
 Ab lKB p65
 Peptide - + - - +
 DEX - - + + +
 NS-e <--p65
 IKB-e
 1 2 3 4 5
 B
 Prim. Ab lKB p65 lKB lKB p65 p65




 Sup. 1 Sup. 2
 Fig. 3. DEX induces new IKB protein synthesis
 and association with preexisting p65. (A) HeLa
 cells were metabolically labeled for 2 hours in the
 absence or presence of 10-7 M DEX, and extracts
 were prepared as described (19). Immunoprecipi-
 tations were done overnight with 1 ,ul of IKBcx or
 p65 antiserum (Ab) to peptide plus 20 ,ul of protein
 A-Sepharose (PAS) either in the absence or pres-
 ence of 1 ,ul of competing peptide (1 mg/ml) as
 indicated. NS, nonspecific. Data are representa-
 tive of seven independent experiments. (B) Six
 HeLa cultures were metabolically labeled for 15
 min, and extracts were pooled and divided into
 two equal portions. Each was immunoprecipi-
 tated overnight with antiserum to peptide as
 above. PAS was pelleted and supernatants were
 collected, and each was divided into two equal
 portions. Supernatants derived from the IKBcx im-
 munoprecipitation (Sup. 1) and the p65 immuno-
 precipitation (Sup. 2) were reimmunoprecipitated
 as above [second antibody (Sec. Ab)]. Immuno-
 precipitations were analyzed as in (A).
 and 2). Analysis of the supernatants indi-
 cated that the antibodies accounted for all
 of the signal (Fig. 3B, Sup. 1 and Sup. 2).
 Thus, all of the surviving newly synthesized
 IKBo protein was rapidly associated with
 NF-KB. This is consistent with the observa-
 tion that free IKBo is intrinsically unstable
 and rapidly degraded (14).
 In the absence of DEX, TNF-ot treat-
 ment results in the transient loss of IKBo,
 which allows NF-KB to translocate to the
 nucleus (12). We wanted to observe the
 effect of TNF-ot treatment on the DEX-
 induced pool of newly synthesized IKBot
 associated with NF-KB. To this end, HeLa
 cultures were metabolically labeled in the
 absence or presence of DEX. TNF-ot was
 then added and extracts were prepared at
 various times. The extracts were immuno-
 precipitated with the p65-specific antibody,
 and the resultant material was analyzed by
 SDS-polyacrylamide gel electrophoresis
 (PAGE). As expected, TNF-ot treatment in
 A
 Peptide + - - - + - -
 DEX - - - - + + + +
 TNF (min) - - 15 30 - - 15 30
 p65o _
 IKBe m
 1 2 3 4 5 6 7 8
 B
 Peptide - - +
 TNF-chase - - - + +
 DEX - + + +
 p65--
 1 2 3 4 5
 Fig. 4. Newly synthesized IKBco reassociates with
 preexisting NF-KB after TNF-cx stimulation. (A)
 HeLa cultures were metabolically labeled in the
 presence or absence of 10-7 M DEX for 2 hours.
 TNF-cx (1 ng/ml) was then added in the presence
 of carrier bovine serum albumin. Extracts were
 prepared by lysis in RIP buffer as described (19)
 and incubated with 1 ,ul of antiserum to p65 in the
 absence or presence of 1 ,ul of competing peptide
 as shown at the top of the panel. PAS pellets were
 extensively washed, and immunoprecipitated
 proteins were analyzed by SDS-PAGE. (B) HeLa
 cultures were metabolically labeled in the pres-
 ence or absence of 10-7 M DEX as described
 above. Plates were washed with PBS and either
 harvested or treated with chase medium contain-
 ing TNF-cx (1 ng/ml). After 30 min, plates were
 harvested and extracts were incubated with anti-
 serum to p65 and processed as described above.
 the absence of DEX resulted in the rapid
 loss of p65-associated IKBo (Fig. 4A). In
 the presence of DEX, the amount of newly
 synthesized IKBo associated with p65 was
 greatly increased (Fig. 4A; compare lanes 2
 and 6). When treated with TNF-ot and
 DEX, the amount of newly synthesized
 IKBot associated with p65 remained elevat-
 ed (Fig. 4A). Thus, DEX treatment stabiliz-
 es the overall association of p65 with the
 pool of newly synthesized IKBot even in the
 presence of an inducer like TNF-ot.
 This result could be explained either by
 the inhibition by DEX of the TNF-ot-me-
 diated release of NF-KB from IKBo (for
 example, by affecting IKBo phosphoryla-
 tion) or by the induction of the reassocia-
 tion of newly synthesized IKBot with newly
 released NF-KB. These possibilities can be
 distinguished by performing a pulse-chase
 experiment and treating HeLa cultures with
 TNF-ot during the chase. Under chase con-
 ditions, newly synthesized IKBo protein has
 a much lower specific activity. Thus, if DEX
 blocks the TNF-ot-mediated release of NF-
 KB, the IKBo signal should remain relative-
 ly unchanged. If, in the presence of TNF-o,
 newly synthesized IKBo (low specific activ-
 ity) replaces preexisting lKBo (high specific
 activity), then the IKBo signal should sub-
 TNF-a
 NF-KBIKBhB





 NF-KB Synthesis Degradation
 Gene
 transcription
 Fig. 5. A model illustrating how DEX treatment
 affects the NF-KB system as a whole. TNF-cx in-
 duction results in the rapid degradation of IKBcx
 and the nuclear translocation of NF-KB (upper di-
 agram). NF-KB either reassociates with a newly
 synthesized IKBLx molecule (thin arrow) or translo-
 cates to the nucleus. Nuclear NF-KB induces tran-
 scription of both p50 and IKBcx genes, as well as
 effector molecules regulating the biological re-
 sponse. In the presence of DEX (lower diagram),
 IKBot synthesis is increased as a result of in-
 creased gene transcription. TNF-cx-mediated nu-
 clear translocation of NF-KB is inhibited by the
 reassociation of NF-KB with newly synthesized
 IKBcx. In addition, DEX renders the remaining NF-
 KB that translocates to the nucleus unable to bind
 DNA (5, 6). Thick arrows represent induced path-
 ways; thin blocked line represents an inhibited
 pathway.
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 stantially decrease. HeLa cultures were met-
 abolically labeled in the absence or pres-
 ence of DEX for several hours. The labeling
 medium was then replaced with chase me-
 dium containing DEX and TNF-ox. Cultures
 were harvested and extracts were immuno-
 precipitated with the p65-specific antibody.
 Under these conditions, the IKBox signal
 rapidly disappeared (Fig. 4B). Thus, DEX
 does not appear to alter the signal transduc-
 tion pathway leading to the induced disso-
 ciation of NF-KB and IKB x.
 Together, these data indicate that DEX
 treatmnent induces the transcription of the
 IKBo- gene. This induction results in the
 increased synthesis of IKBo- protein. This
 increase in protein synthesis leads to the
 rapid turnover of IKB(x protein associated
 with preexisting NF-KB complexes. In the
 presence of an activator suclh as TNF-u_4,
 newly released NF-KB reassociates with the
 DEX-induced IKBox and thus reduces the
 amount of NF-KB translocating to the nu-
 cleus. Additionally, newly synthesized IKB x
 may enter the nucleus and inhibit NF-KB
 DNA binding (15). A model of this process
 is shown in Fig. 5. Consistent with this
 model, we show that the GC-mediated in-
 hibition of NF-KB induction by means of
 TNF-ox is blocked by CHX (Fig. 1). Previ-
 ously we and others showed that activated
 GR could physically associate with NF-KB
 subunits and that DEX represses the DNA
 binding activity of nuclear NF-KB (5, 6).
 Here we demonstrate a second independent
 mechanism through which the NF-KB and
 GC signal transduction systems interact. As
 NF-KB is a critical regulator of cytokine
 genes, the inhibition of the activity of this
 transcription factor would effectively block
 cytokine secretion, thus explaining an im-
 munosuppressive function of GCs. It has
 also been reported recently that salicylates,
 at concentrations corresponding to doses
 prescribed for arthritis patients, also block
 NF-KB activity (16). Thus, NF-KB activa-
 tion serves as a target for two distinct im-
 munosuppressive therapies. The presence of
 multiple levels of interaction between the
 NF-KB and GC systems suggests that these
 interactions may have evolved to serve a
 physiological role in the development of
 the immune system and in modulation of
 the immune response.
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 Immunosuppression by Glucocorticoids:
 Inhibition of NF-KB Activity Through
 Induction of IKB Synthesis
 Nathalie Auphan,*t Joseph A. DiDonato,t Caridad Rosette,
 Arno Helmberg,t Michael Karin?
 Glucocorticoids are among the most potent anti-inflammatory and immunosuppressive
 agents. They inhibit synthesis of almost all known cytokines and of several cell surface
 molecules required for immune function, but the mechanism underlying this activity has
 been unclear. Here it is shown that glucocorticoids are potent inhibitors of nuclear factor
 kappa B (NF-KB) activation in mice and cultured cells. This inhibition is mediated by
 induction of the IKBOL inhibitory protein, which traps activated NF-KB in inactive cyto-
 plasmic complexes. Because NF-KB activates many immunoregulatory genes in response
 to pro-inflammatory stimuli, the inhibition of its activity can be a major component of the
 anti-inflammatory activity of glucocorticoids.
 Glucocorticoids (GCs) are physiological
 inhibitors of inflammatory responses and
 are widely used as immunosuppressive and
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 icine, University of California, San Diego, La Jolla, CA
 92093-0636, USA.
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 anti-inflammatory agents (1). Interference
 with GC action or synthesis increases ani-
 mal mortality after challenge with bacterial
 superantigens (2). GCs induce lymphocyte
 apoptosis (1, 3) and inhibit synthesis of
 lymphokines (4) and cell surface molecules
 required for immune functions (5). In spite
 of the widespread use of GCs, the molecular
 mechanisms that underlie their therapeutic
 effects are poorly understood (1). GCs in-
 duce target genes through the glucocorti-
 coid receptor (GR), a ligand-activated tran-
 scription factor (6). GCs repress gene ex-
 pression through transcriptional interfer-
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